Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.
Suwarti S. et al, (2024), BMC infectious diseases, 24
The effect of pH on the structure of Bluetongue virus VP5.
Zhang H. et al, (2024), The Journal of general virology, 105
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.
Thanh TT. et al, (2024), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies
Clarke JD. et al, (2024), Acta Crystallographica Section F Structural Biology Communications, 80, 154 - 163
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell reports. Medicine
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Nhu LNT. et al, (2024), Wellcome Open Research, 9, 181 - 181
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2024), Nature communications, 15
Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.
Liu C. et al, (2024), Nature communications, 15
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Sidhu JK. et al, (2023), The Journal of infectious diseases
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2023), Nature communications, 14
Structural comparison of typical and atypical E2 pestivirus glycoproteins.
Aitkenhead H. et al, (2023), Structure (London, England : 1993)
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.
Bou-Antoun S. et al, (2023), The Journal of antimicrobial chemotherapy, 78, ii37 - ii42
Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.
Bešević J. et al, (2023), Journal of epidemiology and community health
Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.
El Omari K. et al, (2023), Commun Chem, 6
ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.
Ni T. et al, (2023), iScience, 26
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy.
Ragonnet-Cronin M. et al, (2023), Nat Commun, 14
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Chenthamarakshan V. et al, (2023), Science advances, 9
Broadly neutralizing antibodies against COVID-19.
Zhou D. et al, (2023), Current opinion in virology, 61